This article has multiple issues. Please help improve it or discuss these issues on the talk page. (Learn how and when to remove these messages)
|
David J. Flavell FRCPath is a British academic research scientist who specializes in the development of antibody-based treatments for adults and children with various forms of leukaemia and lymphoma.
David Flavell | |
|---|---|
| Born | Southport, England |
| Occupation | Cancer research scientist |
| Years active | over 40 years |
Early life
editBorn in Southport, Lancashire, in 1953, he obtained his bachelor's degree in applied Biology from Liverpool in 1975, and his Ph.D. in cancer immunology from Sheffield in 1978. He has held posts at the University of Sheffield (1975–78), Mahidol University, Bangkok, Thailand (1978–79), The University of London, London School of Hygiene and Tropical Medicine (1979–1983)[1] and the University of Southampton Medical School (1984–2005).[2] He became a member of The Royal Society of Pathologists in 1997, and later a Fellow of the same Royal Society in 2004.[3]
Career
editWith his wife Sopsamorn and two other couples, Flavell started a children's leukaemia research charity, Leukaemia Busters.[4]
His research is concerned with the development of the next generation of genetically engineered immunotoxins.[5][6]
References
edit- ^ "The London School of Hygiene & Tropical Medicine". LSHTM. 8 November 2024.
- ^ "Staff Profile :: All staff listings - Our staff - Who we are - School of Medicine - University of Southampton". Archived from the original on 19 July 2011. Retrieved 18 July 2019.
- ^ The Royal College of Pathologists. "Homepage". www.rcpath.org.
- ^ Our history. Leukaemia Busters. Accessed May 2023.
- ^ Lombardi, A., Bursomanno, S., Lopardo, T., Traini, R., Colombatti, M., Ippoliti, R., Flavell, D.J., Flavell, S.U., Ceriotti, A. & Fabbrini, M.S. (2010) FASEB J. 24(1) 253-65
- ^ Flavell D. J. Saporin Immunotoxins, Curr Top Microbiol Immunol, 234, 57-61 (1998)